C. Michael Gibson

Showing 1-4 of 4 articles

Short- and long-term mortality following bleeding events in patients undergoing percutaneous coronary intervention: insights from four validated bleeding scales in the CHAMPION trials

Vaduganathan M, Harrington R, Stone GW, Steg P, Gibson M, Hamm C, Price M, Lopes R, Leonardi S, Deliargyris E, Prats J, Mahaffey K, White H, Bhatt D

February 2, 2018 | 10.4244/EIJ-D-17-00723

Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI

Brener S, Dambrink J-H, Maehara A, Chowdhary S, Gershlick A, Généreux P, Koolen J, Mehran R, Fahy M, Gibson C, Stone GW

February 20, 2014 | 10.4244/EIJV9I10A201

Time-related impact of distal embolisation on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperation

De Luca G, Gibson C, Huber K, Dudek D, Cutlip D, Zeymer U, Gyöngyösi M, Bellandi F, Noc M, Arntz H-R, Maioli M, Secco G, Zorman S, Gabriel H, Emre A, Rakowski T, van’t Hof A

August 24, 2012 | 10.4244/EIJV8I4A74

Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials

Navarese E, Kubica J, Castriota F, Gibson M, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S

December 30, 2011 | 10.4244/EIJV7I8A155

1

Latest news

Challenging TAVI anatomies, risk prediction for PCI of CTOs, antithrombotic strategies, and more

NEW ahead of print: FFR and myocardial mass

Post atrioventricular (AV) branch intervention coronary angiogram

CTO Percutaneous Coronary Intervention Scores: Present and Future

Evangelia Vemmou

New Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

February 14, 2020

Guidance Papers

Guidelines, consensus & position papers

Cardiocerebral Continuum in Cognitive Function After TAVI

This week’s JAA’s: Coronary Bifurcation in Asia Pacific, 3year outcomes: Compare-ACUTE...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke